Bezchlibnyk-ButlerKZJeffriesJJ. Clinical handbook of psychotropic drugs. Seattle, Toronto, Goettingen, Bern: Hogrefe and Huber Publishers; 2002.
2.
YeraganiVKBalonRPohlRRameshC.Imipramine treatment and increased serum cholesterol levels. Can J Psychiatry1989;34:845.
3.
YeraganiVKPohlRBalonRRameshCGlitzD.Increased serum total cholesterol to HDL-cholesterol ratio after imipramine. Psychiatr Res1990;32:207–9.
4.
PollockBGPerelJMParadisCFFasiczkaALReynoldsCF3rd.Metabolic and physiologic consequences of nortriptyline treatment in the elderly. Psychopharmacol Bull1994;30:145–50.
5.
de ZwaanMNutzingerDO. Effect of fluvoxamine on total serum cholesterol levels during weight reduction. J Clin Psychiatry1996;57:346–8.
6.
PerryPJGarveyMJDunnerDLRushAJKyhlJ.A report of trazodone-associated laboratory abnormalities. Ther Drug Monit1990;12:517–9.
7.
HickieISimonsLNaismithSSimonsJMcCallumJPearsonK.Vascular risk to late-life depression: Evidence from a longitudinal community study. Aust N Z J Psychiatry2003;37(1):62–5.
8.
PapassotiropoulosAHawellekBFrahnertCRaoGSRaoML. The risk of acute suicidality in psychiatric inpatients increases with low plasma cholesterol. Pharmacopsychiatry1999;32(1):1–4.
9.
EllisonLFMorrisonHI. Low serum cholesterol concentration and risk of suicide. Epidemiology2001;12:168–72.
10.
WeidnerGConnorSLHollisJFConnorWE. Improvements in hostility and depression in relation to dietary change and cholesterol lowering. The Family Heart Study. Ann Intern Med1992;117:820–3.
11.
CoutuMFDupuisGD'AntonoB.The impact of cholesterol lowering on patients' mood. J Behav Med2001;24:517–36.